Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3499
-0.0253 (-6.74%)
At close: Oct 9, 2026, 4:00 PM EDT
0.349736
-0.0002 (-0.05%)
After-hours: Oct 9, 2026, 7:59 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $55.88 million as of October 9, 2026. Its market cap has decreased by 82.08% in one year.
Market Cap
55.88M
Enterprise Value
26.79M
1-Year Change
-82.08%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $55.88M, a decrease of -55.24%. That is a compound annual growth rate of -10.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 55.88M | -15.74% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pliant Therapeutics | 62.23M |
| Eloxx Pharmaceuticals | 60.63M |
| Xilio Therapeutics | 59.88M |
| Kalaris Therapeutics | 59.51M |
| Gossamer Bio | 59.33M |
| Boundless Bio | 58.91M |
| RenovoRx | 58.44M |
| Alterity Therapeutics | 58.34M |